| | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
---|
What is an ATC-Code? | ATC-Overview |
|
L | | IP | | | Azacitidin Stada 150 mg | | 304.64 | 347.75 | 10 % | | Powder for injection suspension: Azacitidinum 150 mg | Spirig HealthCare AG | ● A / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | V/S | Infanrix DTPa-IPV | | PR | PR | k.A. | | 8 Active Agents | GlaxoSmithKline AG | B | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | | | | Rivaroxaban Vascular Zentiva 2,5 mg | 56 | PR | PR | k.A. | | Coated tablets: Rivaroxabanum 2.5 mg | Helvepharm AG | B | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | | | | Rivaroxaban Vascular Zentiva 2,5 mg | 196 | PR | PR | k.A. | | Coated tablets: Rivaroxabanum 2.5 mg | Helvepharm AG | B | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | | Sonotryl | 10 | PR | PR | k.A. | | Coated tablets: Ibuprofenum 200 mg | VERFORA SA | D | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | | Sonotryl | 20 | PR | PR | k.A. | | Coated tablets: Ibuprofenum 200 mg | VERFORA SA | D | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Xenpozyme 4 mg | | PR | PR | k.A. | | poudre pour solution à diluer pour perfusion: Olipudasum Alfa 4 mg | Sanofi-Aventis (Suisse) SA | A | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Xenpozyme 4 mg | 10 | PR | PR | k.A. | | poudre pour solution à diluer pour perfusion: Olipudasum Alfa 4 mg | Sanofi-Aventis (Suisse) SA | A | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Xenpozyme 20 mg | | PR | PR | k.A. | | poudre pour solution à diluer pour perfusion: Olipudasum Alfa 20 mg | Sanofi-Aventis (Suisse) SA | A | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Xenpozyme 20 mg | 10 | PR | PR | k.A. | | poudre pour solution à diluer pour perfusion: Olipudasum Alfa 20 mg | Sanofi-Aventis (Suisse) SA | A | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
L | | IP | CI | A | Subutex 2 mg | 28 Tablet(s) | 25.23 | 43.55 | 10 % | | Sublingual tablets: Buprenorphinum 2 mg | Indivior Schweiz AG | A+ / SL / SO | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | | Dilzem 90 mg retard | 20 Tablet(s) | 3.26 | 12.80 | 10 % | | Delayed release tablets: Diltiazemi Hydrochloridum 90 mg | Pfizer AG | B / SL / SO | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | | Dilzem 90 mg retard | 100 Tablet(s) | 14.05 | 31.70 | 10 % | | Delayed release tablets: Diltiazemi Hydrochloridum 90 mg | Pfizer AG | B / SL / SO | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
L | | IP | CI | | Januvia 100 mg - T | 28 Tablet(s) | 26.82 | 44.80 | 20 % | | Coated tablets: 2 Active Agents | MSD Merck Sharp & Dohme AG | B / SL / SO | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
L | | IP | CI | | Januvia 100 mg - T | 98 Tablet(s) | 93.85 | 115.75 | 20 % | | Coated tablets: 2 Active Agents | MSD Merck Sharp & Dohme AG | B / SL / SO | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
L | | IP | CI | | Januvia 25 mg - T | 28 Tablet(s) | 26.82 | 44.80 | 20 % | | Coated tablets: Sitagliptinum 25 mg | MSD Merck Sharp & Dohme AG | B / SL / SO | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
L | | IP | CI | | Januvia 25 mg - T | 98 Tablet(s) | 93.85 | 115.75 | 20 % | | Coated tablets: Sitagliptinum 25 mg | MSD Merck Sharp & Dohme AG | B / SL / SO | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| SIP | IP | CI | | Xarelto 15 mg | 14 Tablet(s) | 32.17 | 50.00 | 10 % | | Coated tablets: Rivaroxabanum 15 mg | Bayer (Schweiz) AG | B / SL / SO | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| SIP | IP | CI | | Xarelto 15 mg | 28 Tablet(s) | 62.83 | 82.05 | 10 % | | Coated tablets: Rivaroxabanum 15 mg | Bayer (Schweiz) AG | B / SL / SO | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| SIP | IP | CI | | Xarelto 15 mg | 98 Tablet(s) | 230.43 | 257.10 | 10 % | | Coated tablets: Rivaroxabanum 15 mg | Bayer (Schweiz) AG | B / SL / SO | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | | Zyprexa 2,5 mg | 28 Tablet(s) | 29.15 | 47.55 | 20 % | | Coated tablets: Olanzapinum 2.5 mg | Eli Lilly (Suisse) SA | B / SL / SO | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | | Zyprexa 5 mg - T | 28 Tablet(s) | 47.90 | 67.55 | 20 % | | Coated tablets: Olanzapinum 5 mg | Eli Lilly (Suisse) SA | B / SL / SO | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | | Zyprexa 10 mg - T | 28 Tablet(s) | 84.24 | 106.35 | 10 % | | Coated tablets: Olanzapinum 10 mg | Eli Lilly (Suisse) SA | B / SL / SO | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | | Zyprexa 15 mg | 28 Tablet(s) | 122.31 | 147.00 | 20 % | | Coated tablets: Olanzapinum 15 mg | Eli Lilly (Suisse) SA | B / SL / SO | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Fentalis 25 μg/h | 5 | 15.79 | 33.60 | 10 % | | | Sandoz Pharmaceuticals AG | A+ / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Fentalis 50 μg/h | 5 | 31.27 | 50.40 | 10 % | | | Sandoz Pharmaceuticals AG | A+ / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Fentalis 100 μg/h | 5 | 58.80 | 80.35 | 10 % | | | Sandoz Pharmaceuticals AG | A+ / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Fentalis 25 μg/h | 10 | 27.66 | 46.50 | 10 % | | | Sandoz Pharmaceuticals AG | A+ / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Fentalis 50 μg/h | 10 | 56.76 | 78.15 | 10 % | | | Sandoz Pharmaceuticals AG | ● A+ / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Fentalis 100 μg/h | 10 | 103.47 | 128.95 | 10 % | | | Sandoz Pharmaceuticals AG | A+ / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | | Dorzo-Vision 2 % | 5 ml | 9.85 | 27.15 | 10 % | | Eye drops: Dorzolamidum 20 mg/ml | OmniVision AG | B / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | | Dorzo-Vision 2 % | 3 x 5 ml | 21.50 | 39.80 | 10 % | | Eye drops: Dorzolamidum 20 mg/ml | OmniVision AG | B / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
L | | IP | | | Ceftriaxon Labatec 2 g i.v. | 2 g | 9.90 | 27.20 | 10 % | | Dry substance: Ceftriaxonum 2000 mg | Labatec Pharma SA | A / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
L | | IP | | | Ceftriaxon Labatec 2 g i.v. | 10 x 2 g | 84.15 | 107.95 | 10 % | | Dry substance: Ceftriaxonum 2000 mg | Labatec Pharma SA | A / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | CM | Mephadolor 500 Neo ‐ I - T | 10 Tablet(s) | 1.27 | 10.60 | 10 % | | Coated tablets: Acidum Mefenamicum 500 mg | Mepha Pharma AG | B / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | CM | Mephadolor 500 Neo ‐ I - T | 30 Tablet(s) | 3.84 | 13.40 | 10 % | | Coated tablets: Acidum Mefenamicum 500 mg | Mepha Pharma AG | B / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | CM | Mephadolor 500 Neo ‐ I - T | 100 Tablet(s) | 11.14 | 28.55 | 10 % | | Coated tablets: Acidum Mefenamicum 500 mg | Mepha Pharma AG | B / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | | Pregabalin Xiromed 25 mg | 14 | 2.93 | 12.45 | 10 % | | Capsules: Pregabalinum 25 mg | Xiromed SA | B / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | | Pregabalin Xiromed 25 mg | 56 | 8.51 | 25.75 | 10 % | | Capsules: Pregabalinum 25 mg | Xiromed SA | B / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Pregabalin Xiromed 50 mg | 14 | 3.37 | 12.95 | 10 % | | Capsules: Pregabalinum 50 mg | Xiromed SA | B / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Pregabalin Xiromed 50 mg | 84 | 17.92 | 36.10 | 10 % | | Capsules: Pregabalinum 50 mg | Xiromed SA | B / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Pregabalin Xiromed 75 mg | 14 | 3.98 | 13.60 | 10 % | | Capsules: Pregabalinum 75 mg | Xiromed SA | B / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Pregabalin Xiromed 75 mg | 56 | 14.99 | 32.90 | 10 % | | Capsules: Pregabalinum 75 mg | Xiromed SA | B / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Pregabalin Xiromed 100 mg | 84 | 20.14 | 38.55 | 10 % | | Capsules: Pregabalinum 100 mg | Xiromed SA | B / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Pregabalin Xiromed 150 mg | 56 | 20.14 | 38.55 | 10 % | | Capsules: Pregabalinum 150 mg | Xiromed SA | B / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Pregabalin Xiromed 150 mg | 168 | 55.37 | 77.50 | 10 % | | Capsules: Pregabalinum 150 mg | Xiromed SA | B / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Pregabalin Xiromed 200 mg | 84 | 24.89 | 43.85 | 10 % | | Capsules: Pregabalinum 200 mg | Xiromed SA | B / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Pregabalin Xiromed 300 mg | 56 | 24.89 | 43.85 | 10 % | | Capsules: Pregabalinum 300 mg | Xiromed SA | B / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Pregabalin Xiromed 300 mg | 168 | 71.97 | 95.80 | 10 % | | Capsules: Pregabalinum 300 mg | Xiromed SA | B / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | | Budesonid Xiromed 3 mg | 20 | 11.08 | 28.45 | 10 % | | Hartkapsel mit veränderter Wirkstofffreisetzung: Budesonidum 3 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | | Budesonid Xiromed 3 mg | 50 | 27.54 | 46.35 | 10 % | | Hartkapsel mit veränderter Wirkstofffreisetzung: Budesonidum 3 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | | Budesonid Xiromed 3 mg | 100 | 53.68 | 74.80 | 10 % | | Hartkapsel mit veränderter Wirkstofffreisetzung: Budesonidum 3 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Fraxiparine 0,2 mL | 10 syringe(s) | 18.29 | 36.30 | 10 % | | Injection solution: Nadroparinum Calcicum 17 mg | Viatris Pharma GmbH | B / SL | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Fraxiparine 0,3 mL | 2 syringe(s) | 6.37 | 16.15 | 10 % | | Injection solution: Nadroparinum Calcicum 25 mg | Viatris Pharma GmbH | B / SL | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Fraxiparine 0,3 mL | 10 syringe(s) | 33.39 | 52.75 | 10 % | | Injection solution: Nadroparinum Calcicum 25 mg | Viatris Pharma GmbH | B / SL | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Fraxiparine 0,4 mL | 10 syringe(s) | 31.96 | 51.15 | 10 % | | Injection solution: Nadroparinum Calcicum 33 mg | Viatris Pharma GmbH | B / SL | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Fraxiparine 0,6 mL | 10 syringe(s) | 38.94 | 58.75 | 10 % | | Injection solution: Nadroparinum Calcicum 50 mg | Viatris Pharma GmbH | B / SL | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Fraxiparine 0,8 mL | 10 syringe(s) | 69.28 | 91.75 | 10 % | | Injection solution: Nadroparinum Calcicum 67 mg | Viatris Pharma GmbH | B / SL | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Fraxiparine 1 mL | 10 syringe(s) | 91.90 | 116.35 | 10 % | | Injection solution: Nadroparinum Calcicum 83 mg | Viatris Pharma GmbH | B / SL | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Lasix 20 mg/2 mL | 5 ampoule(s) | 1.61 | 11.00 | 10 % | | Injection solution: Furosemidum 20mg / 2ml | Sanofi-Aventis (Suisse) SA | B / SL | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
L | | IP | | PP | Obizur 500 E | 500 IE | 1225.95 | 1298.85 | 10 % | | Lyophilisate and solvent: Susoctocogum Alfa 500 U | Takeda Pharma AG | B / SL | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | | Salofalk 1000 mg | 50 Sachet(s) | 45.04 | 65.40 | 10 % | | Granulate: Mesalazinum 1 g | Dr. Falk Pharma AG | B / SL | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | | Salofalk 1000 mg | 150 Sachet(s) | 114.86 | 141.35 | 10 % | | Granulate: Mesalazinum 1 g | Dr. Falk Pharma AG | B / SL | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | | Salofalk 3 g | 30 Sachet(s) | 78.06 | 101.30 | 10 % | | Granulate: Mesalazinum 3000 mg | Dr. Falk Pharma AG | B / SL | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | | Salofalk 3 g | 90 | 199.05 | 232.90 | 10 % | | Granulate: Mesalazinum 3000 mg | Dr. Falk Pharma AG | B / SL | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
L | | IP | CI | | Renvela 2.4 g | 60 Sachet(s) | 141.67 | 170.50 | 10 % | | Soluble Powder: Sevelameri Carbonas 2400 mg | Sanofi-Aventis (Suisse) SA | B / SL | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
L | | IP | | | Rixathon 500 mg/50 ml | | 1051.32 | 1159.80 | 10 % | | Concentrate for infusion: Rituximabum 500mg / 50ml | Sandoz Pharmaceuticals AG | A / SL | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
L | | IP | | | Rixathon 100 mg/10 ml | 2 | 421.97 | 475.35 | 10 % | | Concentrate for infusion: Rituximabum 100mg / 10ml | Sandoz Pharmaceuticals AG | A / SL | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
L | | IP | | | Vegzelma 100 mg/4 ml | | 257.57 | 296.55 | 10 % | | Concentrate for infusion: Bevacizumabum 100mg / 4ml | iQone Healthcare Switzerland SA | A / SL | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
L | | IP | | | Vegzelma 400 mg/16 ml | | 962.84 | 1063.55 | 10 % | | Concentrate for infusion: Bevacizumabum 400mg / 16ml | iQone Healthcare Switzerland SA | A / SL | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
L | | IP | CI | PP | Elvanse 70 mg | 30 Capsule(s) | 114.64 | 141.10 | 10 % | | Capsules: Lisdexamfetamini Dimesilas 70 mg | Takeda Pharma AG | A+ / SL | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
L | | IP | | PP | Herceptin subkutan 600mg/5ml | | 1484.04 | 1630.40 | 10 % | | Lösung zur subkutanen Injektion: Trastuzumabum 600mg / 5ml | Roche Pharma (Schweiz) AG | A / SL | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
L | | IP | | | Ogivri 150 mg | | 456.84 | 513.25 | 10 % | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Trastuzumabum 150 mg | Medius AG | A / SL | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
L | | IP | | | Kovaltry 500 I.E. | | 426.24 | 478.35 | 10 % | | Pulver und Lösungsmittel zur Herstellung einer Injektions- oder Infusionslösung: Factor Viii Coagulationis Humanus 500 UI | Bayer (Schweiz) AG | B / SL | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
L | | IP | | | Kovaltry 1000 I.E. | | 851.96 | 915.15 | 10 % | | Pulver und Lösungsmittel zur Herstellung einer Injektions- oder Infusionslösung: Factor Viii Coagulationis Humanus 1000 UI | Bayer (Schweiz) AG | B / SL | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
L | | IP | | | Kovaltry 2000 I.E. | | 1699.67 | 1784.90 | 10 % | | Pulver und Lösungsmittel zur Herstellung einer Injektions- oder Infusionslösung: Factor Viii Coagulationis Humanus 2000 UI | Bayer (Schweiz) AG | B / SL | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | V/S | Comirnaty® Original/Omicron BA.1 15/15 µg pro Dosis gebrauchsfertige Injektionsdispersion für Personen ab 18 Jahren | 10 | PR | PR | k.A. | | 2 Active Agents | Pfizer AG | B | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | V/S | Comirnaty® Original/Omicron BA.1 15/15 µg pro Dosis gebrauchsfertige Injektionsdispersion für Personen ab 18 Jahren | 195 | PR | PR | k.A. | | 2 Active Agents | Pfizer AG | B | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | | Bilaxten 6 mg / ml | 5 ml | PR | PR | k.A. | | Eye drops: Bilastinum 6 mg/ml | A. Menarini GmbH | B | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | PP | Obizur 500 E | 500 IE | PR | PR | k.A. | | Lyophilisate and solvent: Susoctocogum Alfa 500 U | Takeda Pharma AG | B | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | PP | Obizur 500 E | 500 IE | PR | PR | k.A. | | Lyophilisate and solvent: Susoctocogum Alfa 500 U | Takeda Pharma AG | B | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | A | Subutex 2 mg | 7 Tablet(s) | 7.04 | 16.30 | k.A. | | Sublingual tablets: Buprenorphinum 2 mg | Indivior Schweiz AG | A+ | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Argatra 100mg/ml | Durchstechflasche(n) à 2.5 ml | PR | PR | k.A. | | Concentrate for infusion: Argatrobanum Monohydricum 100 mg/ml | Mitsubishi Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Lenzburg | B | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Argatra 100mg/ml | 6 1 Durchstechflasche(n) à 2.5 ml | PR | PR | k.A. | | Concentrate for infusion: Argatrobanum Monohydricum 100 mg/ml | Mitsubishi Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Lenzburg | B | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Rixathon 500 mg/50 ml | 2 | PR | PR | k.A. | | Concentrate for infusion: Rituximabum 500mg / 50ml | Sandoz Pharmaceuticals AG | A | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Rixathon 100 mg/10 ml | 3 | PR | PR | k.A. | | Concentrate for infusion: Rituximabum 100mg / 10ml | Sandoz Pharmaceuticals AG | A | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | | Daktarin | 30 g | PR | 19.85 | k.A. | | Cream: Miconazoli Nitras 20 mg | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| SIP | IP | CI | | Xarelto 15 mg | 10 1 Tablet(s) | PR | PR | k.A. | | Coated tablets: Rivaroxabanum 15 mg | Bayer (Schweiz) AG | B | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| SIP | IP | CI | | Xarelto 15 mg | 30 x 1 | PR | PR | k.A. | | Coated tablets: Rivaroxabanum 15 mg | Bayer (Schweiz) AG | B | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| SIP | IP | CI | | Xarelto 15 mg | 100 | PR | PR | k.A. | | Coated tablets: Rivaroxabanum 15 mg | Bayer (Schweiz) AG | B | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | | Dafalgan Grippal | 12 | PR | PR | k.A. | | Granulat zur Herstellung einer Lösung zum Einnehmen: 3 Active Agents | UPSA Switzerland AG | D | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | V/S | Comirnaty | 195 | PR | PR | k.A. | | Konzentrat zur Herstellung einer Injektionsdispersion: Tozinameranum 225 µg | Pfizer AG | B | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Mylotarg 5 mg | | PR | PR | k.A. | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Gemtuzumabum Ozogamicinum 5 mg | Pfizer AG | A | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | | | Ceftriaxon Labatec 500 mg i.v. | 10 x 500 mg | PR | PR | k.A. | | poudre pour solution injectable: Ceftriaxonum 500 mg | Labatec Pharma SA | A | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
|
| | IP | CI | | Trusopt | 5 ml | 10.33 | 27.60 | 10 % | | | Santen SA | B / SL / SO | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | | Trusopt | 3 x 5 ml | 24.15 | 42.50 | 10 % | | | Santen SA | B / SL / SO | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | | Dorzo-Vision 2 % | 5 ml | 9.85 | 27.15 | 10 % | | Eye drops: Dorzolamidum 20 mg/ml | OmniVision AG | B / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |
| | IP | CI | | Dorzo-Vision 2 % | 3 x 5 ml | 21.50 | 39.80 | 10 % | | Eye drops: Dorzolamidum 20 mg/ml | OmniVision AG | B / SL / SG | FB | | G | ![tell a friend](https://ch.oddb.org:443/resources/mail.gif) |